News

Lilly’s Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial
Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company (NYSE:LLY) revealed the topline results of the SURPASS-CVOT Phase 3 trial, which ...
The new weight-loss drugs experts say will be BETTER than Ozempic - from the 'gym in a jab' that builds muscle as you lose fat, to the injection you take just twice a year. And ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.